// App-Quantinova.ai

397 : Activated Natural Killer Cells Are Associated with Poor Clinical Prognosis in High-Risk B- and T- Cell Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Caroline Duault

Principal Investigators

  • Anil Kumar

  • Adeleh Taghi Khani

  • Sung June Lee

  • Lu Yang

  • Min Huang

  • Christian Hurtz

  • Bryan Manning

  • Lucy Ghoda

  • Tinisha McDonald

  • Norman J. Lacayo

  • Kathleen M. Sakamoto

  • Martin P. Carroll

  • Guido Marcucci

  • Jianhua Yu

  • Michael A. Caligiuri

  • Holden T. Maecker

  • Srividya Swaminathan

Medical Centers

  • Institute for Immunity, Transplantation and Infection, Stanford School of Medicine, Stanford, CA

  • Department of Systems Biology, Beckman Research Institute of City of Hope, City of Hope, Duarte, CA

  • Department of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

  • Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA

  • University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

  • Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope, Duarte, CA

  • Hematogic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

  • University of Pennsylvania, Philadelphia, PA

  • Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Duarte, CA

  • Department of Hematology/Hematopoietic Cell Transplantation, The Beckman Research Institute, City of Hope, Duarte, CA

  • City of Hope National Medical Center, Duarte, CA

  • Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA

  • Department of Hematologic Malilgnancies Translational Science, Beckman Research Institute, City of Hope, Duarte, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Natural Killer cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved